CureVac NV Stock Quote CVAC - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.2011

Bid

3.24

Ask

3.26

Volume

1,189,839

3.11 Day's Range 3.30

2.215 52 Week Range 10.57

Market Cap

696.605M

Previous Close

3.11

Open

3.27

Last Trade

3.2592

Last Trade Time

17:51:04

Financial Volume

$ 3,837,925

VWAP

3.2256

Average Volume (3m)

1,369,188

Shares Outstanding

223,988,675

Dividend Yield

PE Ratio

-2.80

Earnings Per Share (EPS)

-1.16

Revenue

61.71M

Net Profit

-260.17M

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.curevac.com

Headquarters

Tubingen, Deu

Founded

1970

CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was $3.11. Over the last year, CureVac NV shares have traded in a share price range of $ 2.215 to $ 10.57.

CureVac NV currently has 223,988,675 shares outstanding. The market capitalization of CureVac NV is $696.60 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.80.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 144 - Report of proposed sale of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1189	-3.5813253012	3.32	3.47	2.95	1184156	3.15924184	CS
4	-0.8989	-21.9243902439	4.1	4.15	2.95	1327305	3.2748203	CS
12	0.6511	25.5333333333	2.55	5.28	2.215	1369188	3.59145019	CS
26	-0.6589	-17.0699481865	3.86	5.28	2.215	1045908	3.48056351	CS
52	-7.0289	-68.7086999022	10.23	10.57	2.215	887797	4.43259821	CS
156	-56.0689	-94.599122659	59.27	75.68	2.215	744992	14.75192614	CS
260	-81.7889	-96.233556889	84.99	133	2.215	820361	35.50741108	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNTGSentage Holdings Inc	$ 3.60 (56.52%)	2.49M
AGRIAgriFORCE Growing Systems Ltd	$ 0.1021 (24.36%)	36.14M
XRTXXORTX Therapeutics Inc	$ 1.90 (18.01%)	2.26k
MAXNMaxeon Solar Technologies Ltd	$ 0.2791 (15.95%)	50.62M
ULYUrgent ly Inc	$ 1.60 (13.48%)	1.38k
SISIShineco Inc	$ 1.40 (-33.96%)	120.1k
NEXINexImmune Inc	$ 3.17 (-19.34%)	315.23k
ASPIASP Isotopes Inc	$ 2.96 (-16.85%)	248.77k
LUXHLuxUrban Hotels Inc	$ 0.1595 (-13.08%)	502.3k
LIPOLipella Pharmaceuticals Inc	$ 0.47 (-11.49%)	275.11k
MAXNMaxeon Solar Technologies Ltd	$ 0.2791 (15.95%)	50.62M
AGRIAgriFORCE Growing Systems Ltd	$ 0.1021 (24.36%)	36.14M
KZIAKazia Therapeutics Ltd	$ 1.17 (-5.65%)	6.41M
NVDANVIDIA Corporation	$ 126.36 (-0.82%)	6.12M
ASTIAscent Solar Technologies Inc	$ 0.1086 (8.28%)	4.98M